| abstract |
The present invention relates to novel and superior compositions of anticancer drugs, preferably taxanes such as paclitaxel and docetaxel, derivatives or analogs thereof, methods of making such compositions and particles within a specific particle size range As well as methods of treating cancer patients with such compositions, wherein the composition achieves a reduction in chemotherapy-induced side effects, particularly a reduction in chemotherapy-induced hair loss. There is substantially no free drug in the composition. |